Dallas, TX – November 9, 2020 – OTC PR WIRE — Puration, Inc. (OTC PINK: PURA) today confirmed the company will publish a multimedia presentation tomorrow, Tuesday, November 10, 2020 unveiling the details of its new hemp lifestyle brand strategy. The presentation comes after the 2020 election results include the legalization of adult use recreation marijuana in four new states – New Jersey, Arizona, Montana and South Dakota. The cannabis sector also stands to enjoy the benefit of the new Biden admiration which has proclaimed support for the decriminalization of marijuana.
“We are pleased to be revealing our evolving strategy for the cannabis sector as the future of the cannabis sector continues to brighten,” said Brian Shibley, CEO of PURA.
The presentation tomorrow is timed in conjunction with the company’s recent purchase of a 72-Acre property in Farmersville, Texas that will serve as the centerpiece to the company’s new hemp lifestyle brand strategy. PURA management anticipates the new hemp lifestyle brand strategy, named “Farmersville Brands” to become a hemp industry-wide recognized brand catalyst advancing the entire hemp sector.
For more information on Puration, visit http://www.purationinc.com
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.